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ABSTRACT
Single nucleotide variants (SNVs) are, together with
copy number variation, the primary source of vari-
ation in the human genome and are associated
with phenotypic variation such as altered response
to drug treatment and susceptibility to disease.
Linking structural effects of non-synonymous
SNVs to functional outcomes is a major issue in
structural bioinformatics. The SNPeffect database
(http://snpeffect.switchlab.org) uses sequence-
and structure-based bioinformatics tools to predict
the effect of protein-coding SNVs on the structural
phenotype of proteins. It integrates aggregation
prediction (TANGO), amyloid prediction (WALTZ),
chaperone-binding prediction (LIMBO) and protein
stability analysis (FoldX) for structural phenotyping.
Additionally, SNPeffect holds information on
affected catalytic sites and a number of post-
translational modifications. The database contains
all known human protein variants from UniProt, but
users can now also submit custom protein variants
for a SNPeffect analysis, including automated struc-
ture modeling. The new meta-analysis application
allows plotting correlations between phenotypic
features for a user-selected set of variants.
INTRODUCTION
Human next-generation sequencing projects currently
generate millions of previously unknown single nucleotide
variants (SNVs) (1). On average, every newly sequenced
genome generates about 300000 novel SNVs (2).
Although it is quite straightforward to annotate these
SNVs according to their genomic location (coding,
non-coding and regulatory regions), and for coding
SNVs to denote their effect on the translated protein (syn-
onymous or non-synonymous), predicting the detailed
effect of a coding mutation on the structure and
function of a protein is a largely unsolved problem. As
these variants can inﬂuence drug selection, dosing and
adverse effects (3), it is recognized that this genetic infor-
mation is of great importance for drug development in
general (4) and crucial for personalized medicine (5).
Most current approaches classify SNVs into neutral or
deleterious variants by using either conservation based
measures (6) or by using a combination of conservation
scores and structural features (7–9). Tools for predicting
stability changes upon mutation have also been developed
(10,11), however these do not use explicit stability predic-
tions based on a high-resolution structure but rather
depend on black-box predictions using intelligent
machine-learning approaches such as support-vector
machines or neural networks.
Coding non-synonymous SNVs can affect protein struc-
ture and function to various degrees (12,13). Although
predicting neutral or fully disruptive variants is relatively
easy, a large portion of variants will result in more subtle
intermediate phenotypic effects that are much more
challenging to predict.
To tackle this challenge web servers such as PolyPhen
(9) and HOPE (8), for example, base their predictions on a
statistical analysis of protein structures extrapolated to the
protein under study and do currently not provide quanti-
tative free energy changes of point mutations. SNPeffect
on the other hand uses the FoldX (14) force ﬁeld and aims
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(G), thereby providing high-accuracy protein stability
information. As structure quality is crucial for the
accuracy of G predictions using FoldX we currently
do not model structures with <90% sequence identity to
the modeling template structure. As a result the structural
coverage of SNPeffect is somewhat lower than that of
PolyPhen or HOPE. However, by integrating several in-
house developed structural bioinformatics tools designed
to quantify protein misfolding (FoldX), protein aggrega-
tion [TANGO (15) and WALTZ (16)] and chaperone
interaction [LIMBO (17)], SNPeffect was developed with
the speciﬁc aim of mapping the effect of SNVs on the
protein homeostasis landscape. i.e. the ability of a cell to
maintain appropriate concentrations of properly folded
proteins in the correct cellular compartment (18).
Currently SNPeffect provides pre-calculated mutant
analyses for more than 60000 human coding protein
variants, beneﬁting the speed of information retrieval,
but it also allows calculation of custom mutant sets.
Finally SNPeffect provides features for meta-analysis of
selected data sets allowing to analyze the proteostatic
landscape of a given protein or protein family for example.
SNPeffect PIPELINE FOR MOLECULAR
PHENOTYPING OF HUMAN PROTEIN VARIANTS
The raw data source of the SNPeffect database consists of
the UniProt human variation database (http://www
.uniprot.org/docs/humsavar), containing single amino
acid polymorphisms, classiﬁed either as disease mutations,
polymorphisms or yet unclassiﬁed mutations. SNPeffect
predicts the impact of these variants on (i) protein aggre-
gation and amyloid formation (TANGO and WALTZ,
respectively), (ii) chaperone binding (LIMBO) and (iii)
structural stability (FoldX). The availability of a crystal
structure with a minimal resolution of 4A ˚ is required to
accurately analyze the effect on protein stability with
FoldX. If an exact structural match is not found, homolo-
gous structures with no <90% sequence identity are con-
sidered as template structures to build a homology model
of the original sequence with FoldX. The stability analysis
is then applied to this model.
Furthermore, SNPeffect holds annotations on function-
al sites, structural features, domain information, cellular
processing and post-translational modiﬁcations for each
variant.
The effect on functional sites and structural features is
analyzed by investigating several properties of the position
of the mutation. Data from the Catalytic Site Atlas
is parsed to analyze whether the residue is part of the
active site (19). Secondary structure information is
generated by FoldX and transmembrane topology (extra-
cellular, intracellular, transmembrane) is predicted by
TMHMM (20). Domain information is provided by
SMART (21) and PFAM (22). PSORT (23) provides a
prediction on the sub-cellular localization. SNPeffect
also maps changes in post-translational lipid anchor at-
tachment and the peroxisomal targeting signal PTS1 (24).
Lipid attachment predictions include myristoylation
(25,26), farnesylation (26), GPI-anchor attachment (27)
and type-1 and type-2 geranylgeranylation (26).
All entries are additionally linked to the OMIM genetic
disorder database (Online Mendelian Inheritance in
Man, OMIM. McKusick-Nathans Institute of Genetic
Medicine, Johns Hopkins University (Baltimore, MD),
2011. World Wide Web URL: http://omim.org/) and the
Gene Ontology database (28).
SNPeffect DATABASE
SNPeffect currently contains data on 63410 human
non-synonymous SNVs. Automatic updates from the
UniProt human variation database are scheduled every
6 months.
The database interface (Figure 1, left) allows users to
search SNVs by ﬁltering on molecular phenotypic effects,
mutation type, disease, UniProt identiﬁer, dbSNP identi-
ﬁer and gene name. Molecular phenotypic effects include
changes in aggregation tendency (dTANGO), amyloid
formation (dWALTZ), chaperone binding (dLIMBO)
and structural stability change upon mutation (ddG).
Applying the ﬁlter settings results in a set of variants
that can be analyzed in a protein-centered or variant-
centered view (Figure 1, right).
This SNPeffect update focuses primarily on the scientist
user’s ability to quickly retrieve and rapidly analyze the
effect of protein variants. Moreover, the wild-type protein
of each variant is also fully analyzed and directly linked
from the variant webpage. The effects are visualized by
self-explanatory barplots and histograms. Structural data
is retrieved from the Protein Data Bank (PDB) (29). When
an exact match to the wild-type sequence is not found, a
homology model is built from a template structure that
has at least 90% sequence identity to the original
sequence. If structural information is retrieved, we offer
visualization of both the wild-type and mutant residue
environment in the protein structure. Additionally, every
phenotypic analysis is accompanied by a graphical and
textual comparison to the wild-type protein. Figure 1
illustrates the summary of a variant that meets the
criteria set in the ﬁlter.
META-ANALYSIS
A new feature in SNPeffect 4.0 is the ability to analyze and
plot phenotypic features of a speciﬁc subset (or all) of the
SNPeffect database. The meta-analysis tool enables scien-
tists to carry out large-scale data mining of the speciﬁed
data and visualize the results in a graphical plot. The data
set of variants is primarily chosen on disease associations
and the mutation type. Mutation types include disease,
polymorphism and unclassiﬁed. An additional ﬁlter can
be applied to limit the results by one or more disease
terms that are selected from a list or speciﬁed by
keywords. SNPeffect will then search for all variants of
the selected type and retrieve those that are linked to the
selected disease(s). For the disease type, these are solely
the mutations annotated with that disease. For the poly-
morphisms and unclassiﬁeds, SNPeffect retrieves all of
D936 Nucleic AcidsResearch, 2012, Vol.40,Database issuethese variants from proteins associated with the selected
disease(s). Next, the two phenotypic effects that will be
analyzed and plotted can be speciﬁed (dTANGO,
dWALTZ, dLIMBO or ddG) (Figure 2). For example,
one can create an aggregation/stability feature plot of a
set of variants to correlate aggregation changes with
Figure 1. Phenotypic summary of a variant. In the form on the left, the ﬁlter settings are selected. The webpage on the right shows a variant that
meets the ﬁlter criteria and displays summarized information on the effect on aggregation tendency, amyloid propensity, chaperone binding and
structural stability, as well as domain annotation from the SMART and PFAM databases. Below the phenotypic summary section, detailed infor-
mation from all predictors can be consulted for an even deeper variant analysis.
Figure 2. Overview of the meta-analysis tool. The left top shows the form to specify which phenotypic features to plot. The bottom images show
(from left to right) a scatter plot, a histogram and a boxplot for the selected data set.
Nucleic Acids Research, 2012,Vol.40, Database issue D937stability changes. If the number of hits for one of the
mutation types exceeds 500, the average Y is plotted for
each X bin, to keep the plots clear and readable. The
meta-analysis tool converts phenotypic features of a
selected set of variants to comprehensible scatter plots,
boxplots and frequency plots (Figure 2).
JOB SUBMISSION
Novel to previous versions of SNPeffect (30–32), the
current version includes a data submission framework
that allows submitting (human or non-human) custom
single protein variants for a detailed SNPeffect analysis
including TANGO, WALTZ, LIMBO and FoldX.
Possible input types are UniProt ID, FASTA sequence,
PDB ID, or an uploaded PDB ﬁle. If only sequence infor-
mation but no structural information is provided,
SNPeffect will search the PDB for a matching structure
to complete the stability analysis with FoldX. When an
exact match is not found, a homology ﬁlter allows setting
the minimum percent sequence identity a structural
homolog template should have to build a homology
model. The effect on structural stability is then determined
by analyzing the homology model. Users receive an e-mail
notiﬁcation when the analysis has ﬁnished and can
download the results from their SNPeffect account. The
results include a PDF ﬁle with the complete phenotypic
SNPeffect analysis. This ﬁle contains ﬁgures and extensive
life scientist-friendly text reports with comparison to the
wild-type protein. All separate ﬁgure ﬁles are also avail-
able and free to use.
SUMMARY
SNPeffect 4.0 offers a detailed and comprehensible mo-
lecular and structural phenotypic analysis of all known
human protein variants. Major phenotypic features such
as aggregation propensity prediction, stability analysis,
structural features, post-translational modiﬁcation and
cellular localization are intelligibly visualized and ex-
plained for each variant. The meta-analysis tool allows
plotting correlations between phenotypic effects concern-
ing a speciﬁed set of variants. Custom protein variants can
now be submitted for a detailed SNPeffect analysis,
including automated structure modeling. SNPeffect 4.0 is
available at http://snpeffect.switchlab.org
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